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The Need for National Registry
Yoga Yuniadi
“Science tells us what we can do;
Guidelines tell us what we should do;
Registries tell us what we are actually doing.”
Currently medical outcomes research has generally been conducted with 3 sources of data: randomized clinical trials, administra-tive claims databases, and data registries. 
Each of these data sources has a unique set of applica-
tions, data quality issues, and requirements.1 In United 
State, clinical trials is part of the pharmaceutical and 
device pre-approval process thus it has highly regu-
lated requirements for source document verification.2 
In contrast, quality control of administrative data is 
primarily limited to fields directly related to claims 
adjudication. Thus, administrative claims data are 
significantly limited for the purposes of performing 
healthcare research.3 Like administrative claims data, 
registries are nonrandomized, observational datasets 
that can be generalized to real-world practice, depend-
ing on the representativeness of participants and the 
completeness of enrollment.4 However, as with the 
data collected in randomized clinical trials, registries 
include detailed clinical data using standardized data 
definitions. 
It always embarrass when lacks of national data lead 
us to present the epidemiology data of other countries. 
Obviously, other country data is not accurately describe 
our real situation. When talking about specific clinical 
situation the availability of Indonesian national data 
is always zero. Then who should be responsible to do 
national survey on detail and specific clinical condi-
tion? Dr. Fadillah Supari, the past Ministry of Health 
of Republic Indonesia is among the first who encour-
age national registry in national health database. Her 
first registry on basic health data is continued by her 
predecessors. Currently, newest basic national health 
data are resulted from national survey conducted on 
2013. However when we try to find special data, for 
example detail cardiovascular diseases, it will end up 
with disappointment as national data did not go fur-
ther into specific area. 
National data on cardiovascular (CV) disease are 
extremely important. The goal is that the national 
CV health registries shall provide current, reliable and 
secure information about the population’s CV health 
and the quality of healthcare. This includes informa-
tion about disease incidence, unexpected changes in 
incidence patterns such as during an epidemic, and 
knowledge about risk factors and causes of disease. To 
achieve this, CV health registries must provide accurate 
and complete information in real time. Cardiovascular 
health registries should be relevant, useful, accessible, 
of high quality, with strong privacy protection, and 
able to provide ongoing analysis and research. For 
special interest on specific data it would be hard to 
lay on government role. Professional society must take 
initiative to collect particular data.
We can learn from European Society of Cardiology 
who decided to make an initiative action on CV 
diseases registries so called EurObservational Research 
Program. They divide the registries into four 
Alamat Korespondensi
Dr. dr. Yoga Yuniadi, SpJP. Divisi Aritmia, Departemen Kardiologi 
dan Kedokteran Vaskular, FKUI dan Pusat Jantung Nasional Harapan 
Kita, Jakarta. E-mail: yogay136@gmail.com
Jurnal Kardiologi Indonesia  
2 Jurnal Kardiologi Indonesia •  Vol. 35, No. 1 • Januari - Maret 2014
categories: (1) General registry is intended to provide 
epidemiological data and reports on application of 
clinical practice guidelines recommendations, (2) 
Sentinel registry to assess the impact of interventional 
procedures and imaging techniques, (3) Special registry 
to assess epidemiology and management of rarer 
conditions as arising critical issues in terms of public 
health (severity of diseases, stringent clinical needs and 
costs), (4) Prevention registry to assess cardiovascular 
risk factors epidemiology and prevention measures. 
Those registries have been scheduled in detail for 
period of more than  five years (Figure 1).5
The contribution of cardiology subspecialty society 
such as Indonesian Society of Interventional Cardiolo-
gist (ISIC), Indonesian Heart Rhythm Society (In-
aHRS) and Indonesian Society of Echocardiography 
(InaEcho) are essential as they have good communi-
cation to facilitate data collection in specific area and 
build effective research collaboration. 
National CV registries have to be organized care-
Figure 1. Clearly shows that acute coronary syndrome, atrial fibrillation , chronic ischemic cardiovascular disease 
and heart failure are considered as general CV problem that its data need to be updated. Some new intervention 
modalities such as mini surgical atrial fibrillation ablation, lead extraction program, transcatheter valve replace-
ment and atrial fibrillation ablation are among area that still need additional data for future development. In our 
country of Indonesia those topics would be much different. Prevention registry need to elaborate the influence 
of carbohydrate rich food on CV disease in our specific population, registry on obesity among urban and 
rural population. Special registry can be done in area of rheumatic heart disease, rheumatic fever, myocarditis 
related to tropical infectious disease, Brudaga syndrome, peripartal cardiomyopathy and sudden cardiac 
death. General survey on acute coronary syndrome, atrial fibrillation and heart failure are also important 
in Indonesia. Primary percutaneous coronary intervention in STEMI patient, atrial fibrillation ablation, 
left atrial appendage closure are among area of interest in sentinel registry.
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fully. One main committee that is responsible for the 
entire program, namely The Oversight Committee 
consist of national key persons. Below the oversight 
committee are two committees that run each study: 
Executive Committee and Steering Committee. The 
coordinating team manages all data collection which 
is responsible for providing organizational support to 
the centers, management of databases, and liaising 
with statistical centers selected by the Executive Com-
mittee of each Survey/Registry, in agreement with the 
Oversight Committee. Data is centralized at PERkI 
House. The main role of the team is to coordinate the 
project, provide support to the Committees, National 
Coordinators and participating centers and ensure that 
the methodological concepts of the survey are adhered 
to. This team has to assure the quality control and con-
tinuity necessary to ensure that projects are completed 
on time and within budget.
Funding is one of essential requirement to perform 
national survey. Considering the importance of accu-
rate CV registry as a basis to develop effective and ef-
ficient government program in reducing morbidity and 
mortality of CV disease, official funding from Ministry 
of Health or Ministry of Research and Technology can 
be expected. Other sources of fund are research grants 
either from industry or government.
As the uses of registry data expand, the need for 
data validation increases. Enhanced data validation 
is necessary to meet stakeholder requirements such 
as those implemented by insurance payers for pay-
for-performance, consumer coalitions for direct-to-
consumer reporting, and government agencies such 
as BPOM for post-approval surveillance using registry 
data. Such initiatives often carry implicit or explicit 
consequences for patients, providers, and manufactur-
ers, further highlighting the need for accuracy.1
In conclusion, national CV registries is essential. 
Indonesian Heart Association (IHA) must take initia-
tive to start the registries hand in hand with govern-
ment and industries. A solid team based at Perki (IHA) 
house coordinates all local team from centers all over 
Indonesia.
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